A J Green

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

Roslyn J. Francis, Sanjay Sharma, Caroline J. Springer et al. · British Journal of Cancer · 2002 · 162 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study

Joanne L. Casey, Mark Napier, David J. King et al. · British Journal of Cancer · 2002 · 43 citations · Full text

Pharmacy, Nuclear Medicine, Oncology +17

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab′ fragments

Joanne L. Casey, RB Pedley, Daniel Griffiths-King et al. · British Journal of Cancer · 1999 · 28 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Mathematical model of antibody targeting: important parameters defined using clinical data

A J Green, Claire Johnson, Kathryn Adamson et al. · Physics in Medicine and Biology · 2001 · 24 citations

Pharmacy, Oncology, Pharmacokinetics +17

Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour

Aiden Flynn, RB Pedley, A J Green et al. · International Journal of Radiation Biology · 2002 · 18 citations

Medicine, Oncology, Radiology +15